Assessment of blood-brain barrier penetration:: In silico, in vitro and in vivo

被引:70
作者
Feng, MR [1 ]
机构
[1] Pfizer Global Res & Dev, Ann Arbor Labs, Ann Arbor, MI 48105 USA
关键词
D O I
10.2174/1389200023337063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amount of drug achieved and maintained in the brain after systemic administration is determined by the agent's permeability at blood-brain barrier (BBB), potential involvement of transport systems, and the distribution, metabolism and elimination properties. Passive diffusion permeability may be predicted by an in silico method based on a molecule's structure property. In vitro cell culture is another useful tool for the assessment of passive permeability and BBB transports (e.g. PGP, MRP). In situ or in vivo techniques like carotid artery single injection or perfusion, brain microdialysis, autoradiography, and others are used at various stages of drug discovery and development to estimate CNS penetration and PK/PD correlation. Each technique has its own application with specific advantages and limitations.
引用
收藏
页码:647 / 657
页数:11
相关论文
共 84 条
[1]  
Abraham MH, 2000, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, P9
[2]   HYDROGEN-BONDING .32. AN ANALYSIS OF WATER-OCTANOL AND WATER-ALKANE PARTITIONING AND THE DELTA-LOG-P PARAMETER OF SEILER [J].
ABRAHAM, MH ;
CHADHA, HS ;
WHITING, GS ;
MITCHELL, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (08) :1085-1100
[3]   HYDROGEN-BONDING .33. FACTORS THAT INFLUENCE THE DISTRIBUTION OF SOLUTES BETWEEN BLOOD AND BRAIN [J].
ABRAHAM, MH ;
CHADHA, HS ;
MITCHELL, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (09) :1257-1268
[4]   DETERMINANTS OF BENZODIAZEPINE BRAIN UPTAKE - LIPOPHILICITY VERSUS BINDING-AFFINITY [J].
ARENDT, RM ;
GREENBLATT, DJ ;
LIEBISCH, DC ;
LUU, MD ;
PAUL, SM .
PSYCHOPHARMACOLOGY, 1987, 93 (01) :72-76
[5]  
BERNSTEIN GY, 2000, POD 2000 AAPS ANN M
[6]   Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats -: A microdialysis study [J].
Bouw, MR ;
Gårdmark, M ;
Hammarlund-Udenaes, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (10) :1220-1227
[7]   How structural features influence the biomembrane permeability of peptides [J].
Burton, PS ;
Conradi, RA ;
Ho, NFH ;
Hilgers, AR ;
Borchardt, RT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1336-1340
[8]   LIPOPHILICITY AND DISPOSITION OF 1-ARYL-PIPERAZINES IN THE RAT [J].
CACCIA, S ;
CONTI, I ;
NOTARNICOLA, A ;
URSO, R .
XENOBIOTICA, 1987, 17 (05) :605-616
[9]  
CACCIA S, 1980, ARCH INT PHARMACOD T, V243, P275
[10]  
Calder J A, 1994, Drug Des Discov, V11, P259